| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 60.915 | 80.413 | 122.747 | 160.849 | 159.873 |
| Total Income - EUR | - | - | - | - | - | 60.915 | 80.413 | 122.747 | 160.849 | 159.873 |
| Total Expenses - EUR | - | - | - | - | - | 58.177 | 68.907 | 105.345 | 146.425 | 136.131 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.738 | 11.507 | 17.402 | 14.424 | 23.742 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.176 | 10.702 | 16.175 | 12.815 | 19.596 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Melifarm Vet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2 | 0 | 0 | 0 | 1.028 |
| Current Assets | - | - | - | - | - | 24.455 | 54.415 | 59.078 | 41.574 | 58.140 |
| Inventories | - | - | - | - | - | 24.184 | 49.376 | 52.993 | 33.655 | 54.802 |
| Receivables | - | - | - | - | - | 0 | 4.957 | 3.006 | 0 | 0 |
| Cash | - | - | - | - | - | 271 | 82 | 3.079 | 7.919 | 3.338 |
| Shareholders Funds | - | - | - | - | - | 2.217 | 10.751 | 26.960 | 28.574 | 43.801 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 22.240 | 43.664 | 32.118 | 13.000 | 15.367 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Melifarm Vet S.r.l.